Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Liver DiseaseAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Haemodynamic definitions and updated clinical classification of pulmonary hypertension.Eur Respir J. 2019; 53: 1801913https://doi.org/10.1183/13993003.01913-2018
- MELD exceptions for portopulmonary hypertension: current policy and future implementation: transplantation in POPH.Am J Transpl. 2014; 14: 2081-2087https://doi.org/10.1111/ajt.12783
- Portopulmonary hypertension: results from a 10-year screening algorithm.Hepatology. 2006; 44: 1502-1510https://doi.org/10.1002/hep.21431
- Pulmonary hypertension in primary biliary cirrhosis: a prospective study in 178 patients.Scand J Gastroenterol. 2009; 44: 219-223https://doi.org/10.1080/00365520802400883
- Clinical risk factors for portopulmonary hypertension.Hepatol Baltim Md. 2008; 48: 196-203https://doi.org/10.1002/hep.22275
- Portopulmonary hypertension: a report from the US-based REVEAL Registry.Chest. 2012; 141: 906-915https://doi.org/10.1378/chest.11-0160
- Survival in portopulmonary hypertension: outcomes of the United Kingdom national pulmonary arterial hypertension registry.J Heart Lung Transpl Off Publ Int Soc Heart Transpl. 2017; 36: 770-779https://doi.org/10.1016/j.healun.2016.12.014
- Pulmonary hypertension complicating portal hypertension.Am Rev Respir Dis. 1979; 120: 849-856https://doi.org/10.1164/arrd.1979.120.4.849
- Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations.J Am Coll Cardiol. 1991; 17: 492-498https://doi.org/10.1016/s0735-1097(10)80121-4
- Clinical aspects of portopulmonary hypertension.Respir Med. 2014; 108: 943-954https://doi.org/10.1016/j.rmed.2014.04.004
- Portopulmonary hypertension: from bench to bedside.Front Med. 2020; 7: 569413https://doi.org/10.3389/fmed.2020.569413
- Hyperthyroidism and pulmonary hypertension: an important association.Am J Med Sci. 2011; 342: 507-512https://doi.org/10.1097/MAJ.0b013e31821790f4
- Endothelial fluid shear stress sensing in vascular health and disease.J Clin Invest. 2016; 126: 821-828https://doi.org/10.1172/JCI83083
- Echocardiography in liver transplant candidates.JACC Cardiovasc Imaging. 2013; 6: 105-119https://doi.org/10.1016/j.jcmg.2012.11.002
- The diagnostic accuracy of Doppler echocardiography in assessment of pulmonary artery systolic pressure: a meta-analysis.Echocardiography. 2013; 30: 258-265https://doi.org/10.1111/echo.12061
- The controversy of right ventricular systolic pressure: is it time to abandon the pulmonary artery catheter?.Anaesthesia. 2015; 70: 241-244https://doi.org/10.1111/anae.12939
- Frequency and outcomes of patients with increased mean pulmonary artery pressure at the time of liver transplantation.Transplantation. 2017; 101: 101-106https://doi.org/10.1097/TP.0000000000001517
- Inaccuracy of Doppler echocardiographic estimates of pulmonary artery pressures in patients with pulmonary hypertension.Chest. 2011; 139: 988-993https://doi.org/10.1378/chest.10-1269
- Portopulmonary hypertension: a survey of practice patterns and provider attitudes.Transpl Direct. 2019; 5: e456https://doi.org/10.1097/TXD.0000000000000900
- Evaluation for liver transplantation in adults.Pract Guideline by AASLD Am Soc Transplant. 2013; 98 (Published online 2013)
- International liver transplant society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension.Transplantation. 2016; 100: 1440-1452https://doi.org/10.1097/TP.0000000000001229
- 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European society of cardiology (ESC) and the European respiratory society (ERS)endorsed by: association for European paediatric and congenital cardiology (AEPC), international society for heart and lung transplantation (ISHLT).Eur Respir J. 2015; 46: 903-975https://doi.org/10.1183/13993003.01032-2015
- Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation.Liver Transpl. 2000; 6: 443-450https://doi.org/10.1053/jlts.2000.6356
- Guidelines on the management of ascites in cirrhosis.Gut. 2021; 70: 9-29https://doi.org/10.1136/gutjnl-2020-321790
- Deleterious effects of β-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension.Gastroenterology. 2006; 130: 120-126https://doi.org/10.1053/j.gastro.2005.10.013
- Pulmonary hypertension: a contraindication to the use of -adrenoceptor blocking agents.Thorax. 2010; 65: 454-455https://doi.org/10.1136/thx.2008.111955
- Pulmonary manifestations of chronic liver disease: a comprehensive review.Ann Gastroenterol. 2020; https://doi.org/10.20524/aog.2020.0474
- The nitric oxide pathway in pulmonary vascular disease.Am J Cardiol. 2017; 120: S71-S79https://doi.org/10.1016/j.amjcard.2017.06.012
- Sildenafil treatment for portopulmonary hypertension.Eur Respir J. 2006; 28: 563-567https://doi.org/10.1183/09031936.06.00030206
- Treatment with sildenafil and treprostinil allows successful liver transplantation of patients with moderate to severe portopulmonary hypertension.Liver Transpl. 2012; 18: 686-695https://doi.org/10.1002/lt.23407
- Riociguat treatment for portopulmonary hypertension: a subgroup analysis from the PATENT-1/-2 studies.Pulm Circ. 2018; 8: 1-4https://doi.org/10.1177/2045894018769305
- The vascular endothelin system in hypertension - recent patents and discoveries.Recent Patents Cardiovasc Drug Discov. 2006; 1: 95-108https://doi.org/10.2174/157489006775244263
- Effect of PAH specific therapy on pulmonary hemodynamics and six-minute walk distance in portopulmonary hypertension: a systematic review and meta-analysis.Pulm Med. 2014; 2014: 1-7https://doi.org/10.1155/2014/528783
- Current and emerging therapeutic approaches to pulmonary hypertension.Rev Cardiovasc Med. 2020; 21: 163https://doi.org/10.31083/j.rcm.2020.02.597
- Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial.Lancet Respir Med. 2019; 7: 594-604https://doi.org/10.1016/S2213-2600(19)30091-8
- Epoprostenol and pulmonary arterial hypertension: 20 years of clinical experience.Eur Respir Rev. 2017; 26: 160055https://doi.org/10.1183/16000617.0055-2016
- Prostacyclin therapies for the treatment of pulmonary arterial hypertension.Eur Respir J. 2008; 31: 891-901https://doi.org/10.1183/09031936.00097107
- Predictors of waitlist mortality in portopulmonary hypertension.Transplantation. 2017; 101: 1609-1615https://doi.org/10.1097/TP.0000000000001666
- Predictors of survival in portopulmonary hypertension: a 20-year experience.Eur J Gastroenterol Hepatol. 2022; 34: 449-456
- Pulmonary vascular resistance predicts mortality and graft failure in transplantation patients with portopulmonary hypertension.Liver Transpl. 2021; 27: 1811-1823https://doi.org/10.1002/lt.26091
- Outcomes of liver transplantation in treated portopulmonary hypertension patients with a mean pulmonary arterial pressure ≥35 mm Hg.Transpl Direct. 2020; 6: e630https://doi.org/10.1097/TXD.0000000000001085
- Clinical outcomes after liver transplantation in patients with portopulmonary hypertension.Transplantation. 2020; 105: 2283-2290
- Portopulmonary hypertension: prevalence, clinical and hemodynamic features.Curr Probl Cardiol. 2021; 46: 100747https://doi.org/10.1016/j.cpcardiol.2020.100747
- Enhancements to the national liver review board, OPTN liver and intestinal organ transplantation committee.(Available at:) (Accessed June 1, 2022)
- Vasomodulators and liver transplantation for portopulmonary hypertension: evidence from a systematic review and meta-analysis.Hepatology. 2020; 72: 1701-1716https://doi.org/10.1002/hep.31164
- Planned initiation of venoarterial extracorporeal membrane oxygenation prior to liver transplantation in a patient with severe portopulmonary hypertension.Liver Transpl. 2021; 27: 760-762https://doi.org/10.1002/lt.25871
- What’s new in the treatment of portopulmonary hypertension?.Expert Rev Gastroenterol Hepatol. 2015; 9: 983-992https://doi.org/10.1586/17474124.2015.1035647
- Long-term outcome in liver transplantation candidates with portopulmonary hypertension: savale et al.Hepatology. 2017; 65: 1683-1692https://doi.org/10.1002/hep.28990
- Portopulmonary hypertension in the current era of pulmonary hypertension management.J Hepatol. 2020; 73: 130-139https://doi.org/10.1016/j.jhep.2020.02.021
- Clinical outcomes after liver transplantation in patients with portopulmonary hypertension.Transplantation. 2021; 105: 2283-2290
Article info
Publication history
Published online: October 18, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
